EMEA-003454-PIP01-23 - paediatric investigation plan

mometasone furoate

Key facts

• Active substance:
  mometasone furoate
• Therapeutic area:
  Infections and infestations
• Decision number:
  P/0184/2024
• PIP number:
  EMEA-003454-PIP01-23
• Pharmaceutical form(s):
  Implant
• Condition(s) / indication(s):
  Treatment of chronic rhinosinusitis
• Route(s) of administration:
  Endosinusial use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  17/05/2024
• Compliance check done:
  No

Decision

P/0184/2024 : EMA decision of 17 May 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for mometasone furoate (EMEA-003454-PIP01-23)

Adopted Reference Number: EMA/226770/2024